2022 Q3 Form 10-Q Financial Statement

#000155837022012069 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $60.15M $29.94M $26.02M
YoY Change 92.27% -11.4% 80.76%
% of Gross Profit
Research & Development $19.84M $10.51M $61.86M
YoY Change -65.13% -86.27% -32.62%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $154.8M -$61.29M $87.88M
YoY Change 55.97% -155.54% -17.25%
Operating Profit -$154.8M $61.29M -$87.88M
YoY Change 55.97% -155.54% -17.25%
Interest Expense $1.062M $383.0K -$258.0K
YoY Change 11700.0% 47.31% -303.15%
% of Operating Profit 0.62%
Other Income/Expense, Net -$643.0K $1.991M -$1.492M
YoY Change -118.55% 6.07% -92.2%
Pretax Income -$154.4M $63.66M -$89.63M
YoY Change 61.19% -158.83% -28.41%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$154.4M $63.66M -$89.60M
YoY Change 61.19% -158.83% -28.44%
Net Earnings / Revenue
Basic Earnings Per Share -$0.73 $0.32 -$0.46
Diluted Earnings Per Share -$728.6K $0.32 -$0.43
COMMON SHARES
Basic Shares Outstanding 205.9M 200.8M 196.5M
Diluted Shares Outstanding 211.9M 201.0M 196.5M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $203.5M $235.7M $203.6M
YoY Change -12.96% -35.59% -65.32%
Cash & Equivalents $154.2M $235.7M $203.6M
Short-Term Investments $49.30M
Other Short-Term Assets $37.46M $43.08M $34.37M
YoY Change 63.48% 124.52% 32.26%
Inventory $11.18M $4.013M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $252.2M $282.8M $237.9M
YoY Change -1.78% -26.57% -61.19%
LONG-TERM ASSETS
Property, Plant & Equipment $220.0M $286.9M $407.8M
YoY Change -39.29% 0.22% 163.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.88M $27.49M $14.00M
YoY Change 486.99% 478.67%
Total Long-Term Assets $248.9M $315.4M $422.8M
YoY Change -32.21% 4.39% 154.64%
TOTAL ASSETS
Total Short-Term Assets $252.2M $282.8M $237.9M
Total Long-Term Assets $248.9M $315.4M $422.8M
Total Assets $501.1M $598.2M $660.8M
YoY Change -19.68% -12.96% -15.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.63M $12.98M $13.78M
YoY Change -67.87% -73.4% -76.63%
Accrued Expenses $34.36M $39.28M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $13.50M $13.50M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $86.15M $60.83M $203.1M
YoY Change -1.94% -25.25% 203.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.495M $1.601M $3.189M
YoY Change -29.3% -76.71% -58.85%
Total Long-Term Liabilities $2.495M $1.601M $3.189M
YoY Change -29.3% -76.71% -63.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $86.15M $60.83M $203.1M
Total Long-Term Liabilities $2.495M $1.601M $3.189M
Total Liabilities $88.64M $62.44M $206.2M
YoY Change -3.0% -29.25% 172.21%
SHAREHOLDERS EQUITY
Retained Earnings -$725.2M -$570.8M -$634.4M
YoY Change 56.39% 55.15% 144.33%
Common Stock $22.00K $21.00K $20.00K
YoY Change 22.22% 16.67% 11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $412.4M $535.8M $454.5M
YoY Change
Total Liabilities & Shareholders Equity $501.1M $598.2M $660.8M
YoY Change -19.68% -12.96% -15.19%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$154.4M $63.66M -$89.60M
YoY Change 61.19% -158.83% -28.44%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$49.59M -$52.39M -$69.03M
YoY Change -33.75% -47.53% -3.48%
INVESTING ACTIVITIES
Capital Expenditures -$10.52M -$18.15M $21.90M
YoY Change -86.84% -85.04% -59.65%
Acquisitions
YoY Change
Other Investing Activities -$48.04M $24.05M
YoY Change
Cash From Investing Activities -$58.56M $5.906M -$21.90M
YoY Change -26.73% -104.87% -59.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $477.0K
YoY Change -54.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.71M 78.61M 50.48M
YoY Change 17.52% 163670.83% -39.23%
NET CHANGE
Cash From Operating Activities -49.59M -52.39M -69.03M
Cash From Investing Activities -58.56M 5.906M -21.90M
Cash From Financing Activities 26.71M 78.61M 50.48M
Net Change In Cash -81.45M 32.12M -40.45M
YoY Change -38.32% -114.53% -5.3%
FREE CASH FLOW
Cash From Operating Activities -$49.59M -$52.39M -$69.03M
Capital Expenditures -$10.52M -$18.15M $21.90M
Free Cash Flow -$39.07M -$34.25M -$90.93M
YoY Change -872.08% -259.41% -27.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12979000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12098000
CY2022Q2 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
34355000
CY2021Q4 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
35507000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.33
ride Proceeds From Down Payment
ProceedsFromDownPayment
82016000
CY2021Q4 ride Lease Deposit Liability Current
LeaseDepositLiabilityCurrent
100000000
CY2022Q2 us-gaap Debt Current
DebtCurrent
13500000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
60834000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1877000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
499000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17255000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
205871561
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-233411000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121427000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196391349
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
21000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1106521000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1084390000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-570783000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544809000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
383000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
535759000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
539600000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
598194000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
688783000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29941000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33793000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55960000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
48187000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10510000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
260000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76544000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72374000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
168356000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
101736000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
125000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
387000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
101736000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
101736000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-171374000
ride Other Non Cash Changes
OtherNonCashChanges
9123000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
-61285000
ride Other Non Cash Changes
OtherNonCashChanges
18261000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
110337000
us-gaap Operating Expenses
OperatingExpenses
26598000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1015000
us-gaap Operating Expenses
OperatingExpenses
216543000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
147605000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
61285000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-110337000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
dei Entity Central Index Key
EntityCentralIndexKey
0001759546
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196400000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
205900000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
205871561
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196391349
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38821
dei Entity Registrant Name
EntityRegistrantName
Lordstown Motors Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2533239
dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Hallock Young Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Lordstown
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44481
dei City Area Code
CityAreaCode
234
dei Local Phone Number
LocalPhoneNumber
285-4001
dei Security12b Title
Security12bTitle
Class A Common Stock
dei Trading Symbol
TradingSymbol
RIDE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
205871561
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235686000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27487000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26598000
us-gaap Operating Income Loss
OperatingIncomeLoss
-216543000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25974000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244016000
CY2022Q2 us-gaap Inventory Net
InventoryNet
4013000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43080000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47121000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
282779000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
291137000
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1601000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1578000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
286928000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382746000
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1000000
CY2022Q2 us-gaap Liabilities
Liabilities
62435000
CY2021Q4 us-gaap Liabilities
Liabilities
149183000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1000000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13900000
CY2022Q2 us-gaap Assets
Assets
598194000
CY2021Q4 us-gaap Assets
Assets
688783000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1991000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63659000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108200000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
63659000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-108200000
us-gaap Net Income Loss
NetIncomeLoss
-25974000
us-gaap Net Income Loss
NetIncomeLoss
-233411000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.33
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
200821000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
176585000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198674000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175595000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
201015000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176585000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198674000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175595000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
454503000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1237000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2626000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
63659000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
535759000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
703315000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3840000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-108200000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
599003000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
539600000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1853000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6546000
us-gaap Net Income Loss
NetIncomeLoss
-25974000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
535759000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
630738000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1098000
ride Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
194798000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5780000
us-gaap Net Income Loss
NetIncomeLoss
-233411000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
599003000
us-gaap Profit Loss
ProfitLoss
-25974000
us-gaap Profit Loss
ProfitLoss
-233411000
us-gaap Share Based Compensation
ShareBasedCompensation
6546000
us-gaap Share Based Compensation
ShareBasedCompensation
5780000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40043000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13413000
ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
31057000
ride Proceeds From Down Payment
ProceedsFromDownPayment
13500000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5301000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-726000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1197000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7209000
ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
-2471000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
175601000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
13500000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
37553000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15990000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-175601000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
100000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1853000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1098000
ride Proceeds From Equity Based Line Of Credit
ProceedsFromEquityBasedLineOfCredit
13734000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
129087000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83114000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8330000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-263861000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244016000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629761000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
235686000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
365900000
ride Application Of Foxconn To Sale Of Capital Assets
ApplicationOfFoxconnToSaleOfCapitalAssets
200000000
ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
1846000
ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
14631000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235700000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-570800000
us-gaap Net Income Loss
NetIncomeLoss
-26000000.0
us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates in Financial Statement Preparation</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, if any, at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-877000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-277000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82000000.0
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1797000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18261000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
286928000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
382746000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
286928000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382746000
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
101700000
us-gaap Depreciation
Depreciation
0
CY2021 us-gaap Depreciation
Depreciation
0
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
4000000.0
CY2022Q2 ride Shares Authorized Common And Preferred
SharesAuthorizedCommonAndPreferred
312000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
205900000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196400000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
200821000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
176585000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198674000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175595000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
201015000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176585000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198674000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175595000

Files In Submission

Name View Source Status
0001558370-22-012069-index-headers.html Edgar Link pending
0001558370-22-012069-index.html Edgar Link pending
0001558370-22-012069.txt Edgar Link pending
0001558370-22-012069-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ride-20220630.xsd Edgar Link pending
ride-20220630x10q.htm Edgar Link pending
ride-20220630x10q_htm.xml Edgar Link completed
ride-20220630xex10d6.htm Edgar Link pending
ride-20220630xex10d7.htm Edgar Link pending
ride-20220630xex31d1.htm Edgar Link pending
ride-20220630xex31d2.htm Edgar Link pending
ride-20220630xex32d1.htm Edgar Link pending
ride-20220630xex32d2.htm Edgar Link pending
ride-20220630_cal.xml Edgar Link unprocessable
ride-20220630_def.xml Edgar Link unprocessable
ride-20220630_lab.xml Edgar Link unprocessable
ride-20220630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending